Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScancell Holdings Share News (SCLP)

Share Price Information for Scancell Holdings (SCLP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 10.10
Bid: 9.70
Ask: 10.50
Change: 0.00 (0.00%)
Spread: 0.80 (8.247%)
Open: 10.10
High: 10.10
Low: 10.10
Prev. Close: 10.10
SCLP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS: Miners Continue Run, Oil Companies Fall

Tue, 14th Oct 2014 11:09

LONDON (Alliance News) - The following stocks are amongst the biggest risers and fallers within the main London indices midday Tuesday.
-------
FTSE 100 WINNERS
-------
Rio Tinto, up 2.2%, Anglo American, up 1.7%, Glencore, up 1.2%, BHP Billiton, up 1.0%, and Fresnillo, up 0.9%. According to an analyst, the mining stocks are continuing the run that started Monday in the wake of positive Chinese export data which signalled some strength in the country's economy. China is responsible for a large portion of the demand for mining products, therefore a strong Chinese economy is seen as positive news for miners.

International Consolidated Airlines Group, up 0.5%. HSBC has raised the company to Overweight from Neutral with a price target increase to 400.00 pence from 380.00p. The stock currently trades at 325.70p.
-------
FTSE 100 LOSERS
-------
Burberry Group, down 4.1%. The British luxury fashion retailer said sales growth slowed in the second quarter as its key travelling Chinese consumers splurged out less on its clothes and leather goods, and it warned that weak consumer confidence in Europe and slower Asian growth would weigh on its second half. The company said revenue rose 14% on an underlying basis in the six months to September 30, to GBP1.1 billion, buoyed by 15% sales growth in retail revenue, and 13% growth in wholesale revenue. It said licensing revenue was down 3% on an underlying basis. On a reported basis, retail and wholesale sales were up only 8%, while licensing revenue was down 18%, which marked a slowdown from the first quarter when it had reported underlying sales growth of 17%, or 9% on a reported basis. Comparable retail sales growth in the first quarter was 12%, but slowed to 8% in the second quarter. Burberry said it now expects a smaller profit hit from currency moves than previously expected for the full financial year. It also warned of a "tougher macro environment" for the second half, but would not clarify what the more "difficult" environment for the remainder of the year would be.

Hargreaves Lansdown, down 2.9%. The investment management company reported a GBP100.0 million increase in assets under administration over the course of the traditionally quiet first quarter, but said levels of net new business were lower than in the corresponding period last year amid uncertainty over the Scottish independence referendum, concern over Middle East and Ukrainian conflicts and unfavourable Eurozone economic data. Hargreaves Lansdown reported GBP970.0 million of net new business inflows in the quarter ended September 30, compared with GBP1.26 billion in the corresponding quarter last year.

Tullow Oil, down 1.6%, BP, down 1.6%, and BG Group, down 1.4%. The companies are down after the price of Brent Oil fell to a near four-year low at USD87.55 a barrel on Tuesday morning.
-------
FTSE 250 WINNERS
-------
Bellway, up 3.4%. The UK housebuilder reported a jump in full-year profit as higher sales volumes at higher average prices lifted revenue by a third, and the company predicted further volume growth in the current year, albeit at a slower rate. The company reported a pretax profit of GBP245.9 million for the year to end-July, up from GBP140.9 million a year earlier, as revenue rose to GBP1.49 billion, from GBP1.11 billion. It also raised its total dividend to 52.0 pence, from 30.0 pence, on the back of the strong results, meaning it will have returned over GBP220 million to shareholders since 2007. The final dividend will be 36.0p, up from 21.0p. It said the total dividend is covered by earnings 3.0 times, a level it expects to maintain for the foreseeable future.

Afren, up 2.6%. The oil and gas explorer and producer confirmed that it has terminated the employment of Chief Executive Osman Shahenshah and Chief Operating Officer Shahid Ullah with immediate effect, firing them for gross misconduct based on evidence found by a review that unearthed irregular payments and starting legal proceedings to recover money from them. It also fired Associate Directors Iain Wright and Galib Virani with immediate effect for the same reasons, and started disciplinary action against seven more employees who it said also received payments.

Just Retirement Group, up 1.6%. The specialist insurer said it has completed its largest defined benefit de-risking transaction, a buy-in deal for GBP75 million which was contracted in September. In a statement, the company said it can't disclose the full details of the deal until all the scheme's members have been told the particulars, but it will provide a bulk annuity contract to the scheme trustees to cover all pensioner members and the deal marks it first completed transaction with the employee benefit consultant advising on the scheme.
-------
FTSE 250 LOSERS
-------
Michael Page International, down 10%. The recruitment company took a seven percentage point hit to its gross profit and said adverse currency movements will contribute to the group's operating profit growth coming in below market expectations. The company said its gross profit grew 11.6% on a constant currency basis in the quarter to September 30, with positive results coming from all four of its operating regions. On an actual currency basis, however, gross profit for the group increased only 4.7% as it was hit by the strength of sterling. Asia Pacific gross profit rose 2.9% to GBP28 million on an actual currency basis, up 11.1% on constant currency, while its Americas business posted a decline in its reported gross profit of 0.8% to GBP20 million, despite rising 9.6% on a constant currency basis.

Balfour Beatty, down 3.6%. The struggling engineering and construction company has issued a last-ditch warning to investors that failure to sell its American arm could result in it defaulting on its debts, The Daily Telegraph reported. In a circular posted to shareholders, the company revealed that it could breach its banking covenants in the coming months if the sell-off of Parsons Brinckerhoff is not approved, the newspaper said.

Ashmore Group, down 2.7%. The emerging markets asset manager reported a USD3.7 billion fall in assets under management over the course of the first quarter, citing negative investment performance of USD3.4 billion and net outflows of USD300 million. In a statement, the company said assets under management fell to USD71.3 billion at the end of September from USD75.0 billion at the end of June. Chief Executive Mark Coombs said the decline in assets under management over the quarter was primarily due to the "correction" in the markets towards the end of the period, driven by the strength of the US dollar.

Essentra, down 1.4%. The packaging components company has had its price target cut by three banks after Monday's trading update. Goldman Sachs has reduced its price to 970.00p from 1,000.00p keeping its Buy rating, JP Morgan cut its target price to 802.00p from 906.00p, with an Overweight rating, and Deutsche Bank cut its price to 840.00p from 920.00p with a Buy rating. The company currently trades at 688.00p.
-------
AIM ALL-SHARE WINNERS
-------
Global Energy Development, up 50%. The Latin America-focused petroleum explorer and producer has agreed to sell the rights and obligations of its contract areas within the Llanos Basin for USD50 million in cash to a subsidiary of TSX-listed oil and gas exploration company Platino Energy Corp. The company said it will use part of the proceeds to eliminate its its outstanding debt balance of USD7.5 million, and will decide what to do with the rest after the deal closes.

Allocate Software, up 34%. The company's board has recommended a takeover offer from an HgCapital Group takeover vehicle that would value the company at around GBP109.6 million. The vehicle has made an offer at 153.55 pence per share, which it said is a 35.3% increase on Allocate's closing price of 113.5 pence Monday. The acquisition is subject to approval from shareholders at the company's annual general meeting, and HGCapital has received acceptances for around 47.1% of Allocate's issued share capital. It needs at least 75% approval to pass. Allocate's board said that it considers the acquisition price to represent a "full and fair value to shareholders, providing certainty through the opportunity to realise value now for their current holdings in cash."

Solo Oil, up 14%. The company said it has signed a deal with Aminex to buy up to 13% of the Kiliwani North Development Licence in Tanzania. Solo said it would buy an initial 6.5% interest in the licence from Aminex-owned Ndovu Resources Ltd for USD3.5 million. The company also holds a 45-day option to increase its interest in the licence by a further 6.5% to 13%.

Scancell Holdings, up 9.6%. The company said it has seen positive results for its SCIB1 trials on a malignant melanoma treatment. Scancell said it has seen strong survival and safety data from the Phase 1 and 2 clinical trials conducted on SCIB1, its ImmunoBody platform vaccine. The results showed the product has the potential to become the first effective standalone treatment for adjuvant melanoma, it added. Adjuvant therapy is treatment provided in addition to the primary, main or initial treatment.
-------
AIM ALL-SHARE LOSERS
-------
Caledonia Mining, off 13%. The company said its earnings for the full year will be "materially lower" than current market expectations, after production fell at its Blanket Mine in Zimbabwe in its third quarter. Caledonia produced 9,890 ounces of gold at Blanket in the third quarter to end-September, down from 12,042 ounces in the previous year and 11,223 ounces in the previous quarter. The average head grade was lower than in previous quarter, and the tonnes mined and milled did not increase sufficiently to offset this, although plant recoveries have remained strong, Caledonia said. As a result, Caledonia lowered its gold production guidance for the year to 40,000 ounces from 45,000 ounces. It produced 31,354 ounces in the first nine months.

Immunodiagnostic Systems Holdings, down 13%. The company said it expects its revenue for the first half to be down on the previous year, as the near-term trading environment for its business "remains challenging." As it has previously flagged up in August and September, the company has seen a low level of placements, meaning instruments sold or leased to customers, and a faster decline in manual revenues, driven by lower 250H Vitamin D sales. This means it now expects revenues to GBP22 million in the first half to end-September, compared to GBP27 million a year before. Automated revenues fell by around 9% compared to the previous year as it saw number of instrument returns, and continued price pressure on its automated Vitamin D assay.

Mulberry Group, down 9.9%. The luxury bags, clothes and accessories maker gave a bleak outlook for the remainder of its financial year, after it said revenue in the first half fell 17% to GBP64.7 million, compared with GBP78.1 million the prior year, and warned its pretax profit for the full year to end of March 2015 will be "significantly below current expectations".
-------

By Neil Thakrar; neilthakrar@alliancenews.com

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
29 Aug 2023 14:27

Scancell appoints healthcare finance veteran as new CFO

(Sharecast News) - Immunotherapy developer Scancell announced the appointment of Sath Nirmalananthan as its new chief financial officer on Tuesday, effective immediately.

Read more
29 Aug 2023 09:53

IN BRIEF: Scancell appoints Prenetics' Sath Nirmalananthan as new CFO

Scancell Holdings PLC - Nottingham, England-based cancer immunotherapies developer - Hires Sath Nirmalananthan to be chief financial officer, starting immediately. Nirmalananthan previously was CFO for Europe, Middle East & Africa at Prenetics Ltd, a genomics-driven health sciences company. His appointment at Scancell follows Keith Green's retirement as director of finance.

Read more
31 Jul 2023 10:46

AIM WINNERS & LOSERS: Aptamer reshuffles board; Scancell expands trial

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
31 Jul 2023 10:23

Scancell shares jump on trial expansion for Modi-1 vaccine

(Alliance News) - Scancell Holdings PLC on Monday said it has expanded its Modi-1 trial for the use of checkpoint inhibitors on cancer patients.

Read more
10 Jul 2023 11:45

IN BRIEF: Scancell to focus on cancer vaccine assets amid trial data

Scancell Holdings PLC - Nottingham, England-based cancer immunotherapies developer - Will focus on lead cancer vaccine assets SCIB1 and Modi-1 following encouraging data from clinical trials. Adds phase two single arm scope trial investigating the safety and tolerability of using SCIB1 in combination with checkpoint inhibitors in patients with advanced melanoma is progressing well and notes a potential pathway for a registration trial. Adds it is fully funded to the second half of 2024 due to its increasing focus on the two clinical assets.

Read more
2 Jun 2023 13:18

Scancell to present positive recent findings at oncology summit

(Sharecast News) - Immunotherapy developer Scancell said on Friday that it is set to present an informative poster at the American Society of Clinical Oncology Meeting (ASCO) 2023 annual meeting in Chicago from 2 to 6 June.

Read more
13 Mar 2023 12:18

SUMMARY: London listings with exposure to Silicon Valley Bank

(Alliance News) - The following is a round-up of updates on exposure to Silicon Valley Bank by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
21 Feb 2023 12:14

Scancell shares jump on positive cancer vaccine progress

(Sharecast News) - Immunotherapy developer Scancell announced the completion of the monotherapy dose-finding arm of the phase 1 and 2 'ModiFY' clinical trial on Tuesday.

Read more
21 Feb 2023 11:56

Scancell shares up on encouraging data from ModiFY cancer trial

(Alliance News) - Scancell Holdings PLC on Tuesday said that it has completed the monotherapy dose finding arm of its multicentre Phase 1/2 ModiFY clinical trial, designed to treat cancer patients.

Read more
13 Feb 2023 11:38

Scancell gets positive result from needle-free Covid vaccines trial

(Alliance News) - Scancell Holdings PLC on Monday reported a positive response in its 'Covidity' trial, which aims to deliver needle-free injectable Covid vaccines.

Read more
1 Feb 2023 21:41

TRADING UPDATES: PetroNeft extends maturity; NetScientific loses chair

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
25 Jan 2023 14:43

TRADING UPDATES: Van Elle and Hargreaves Services post profit rises

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
18 Jan 2023 15:50

UK earnings, trading statements calendar - next 7 days

Thursday 19 January 
AJ Bell PLCTrading Statement
Bakkavor Group PLCTrading Statement
BHP Group LtdTrading Statement
boohoo Group PLCTrading Statement
Centamin PLCTrading Statement
Deliveroo PLCTrading Statement
Dunelm Group PLCTrading Statement
Energean PLCTrading Statement
Frontier Developments PLCHalf Year Results
Harbour Energy PLCTrading Statement
Headlam Group PLCTrading Statement
Ilika PLCHalf Year Results
Kier Group PLCTrading Statement
Luceco PLCTrading Statement
Network International Holdings PLCTrading Statement
Premier Foods PLCTrading Statement
Sage Group PLCTrading Statement
Zotefoams PLCTrading Statement
Friday 20 January 
4imprint Group PLCTrading Statement
Close Brothers Group PLCTrading Statement
Goldplat PLCFull Year Results
Ninety One PLCTrading Statement
Workspace Group PLCTrading Statement
PensionBee Group PLCTrading Statement
TheWorks.co.uk PLCHalf Year Results
Monday 23 January 
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Tuesday 24 January 
Accrol Group Holdings PLCHalf Year Results
Associated British Foods PLCTrading Statement
Henry Boot PLCTrading Statement
Oxford BioDynamics PLCFull Year Results
Saga PLCTrading Statement
Staffline Group PLCTrading Statement
Sureserve Group PLCFull Year Results
Velocity Composites PLCFull Year Results
Wednesday 25 January 
CMC Markets PLCTrading Statement
Conduit Holdings LtdTrading Statement
easyJet PLCTrading Statement
Forterra PLCTrading Statement
Hargreaves Services PLCHalf Year Results
hVIVO PLCTrading Statement
JD Wetherspoon PLCTrading Statement
Keywords Studios PLCTrading Statement
Quilter PLCTrading Statement
Scancell Holdings PLCHalf Year Results
Tullow Oil PLCTrading Statement
Van Elle Holdings PLCHalf Year Results
Watkin Jones PLCFull Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
7 Nov 2022 12:56

Scancell in-licences SNAPvax technology for its Modi-2 cancer treatment

(Alliance News) - Scancell Holdings PLC on Monday said it has in-licensed SNAPvax technology from Vaccitech PLC to help develop its cancer treatments.

Read more
7 Nov 2022 09:29

Scancell licenses Vaccitech IP for its next vaccine candidate

(Sharecast News) - Scancell has in-licensed 'SNAPvax' technology from clinical-stage biopharmaceutical company Vaccitech, it announced on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.